Home > Products > IGF2R & MET > Anti-IGF2R x Anti-MET Bispecific aptamer (DNA/DNA)

Anti-IGF2R x Anti-MET Bispecific aptamer (DNA/DNA)  (CAT#: KN-0825-JL74)

Anti-IGF2R x Anti-MET Bispecific aptamer (DNA/DNA) consists of an anti-CD44 DNA aptamer and an anti-MET DNA aptamer. It has 1+1 antigen-binding valency for IGF2R and MET respectively. This bispecific aptamer (BsApt) can lead MET to lysosomes for degradation. It is designed for the research of targeted protein degradation, and targeted cancer therapy further.
Datasheet INQUIRY

Specifications

Targets
IGF2R & MET
Type
Bispecific Aptamer
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Cancers

Targets

Target 1
IGF2R
Gene ID
UniProt ID
Alternative Names
M6PR; Insulin-like growth factor 2 receptor; IGF2R; insulin like growth factor 2 receptor; MPR1; MPRI; CD222; CIMPR; M6P-R; MPR300; CI-M6PR; MPR 300; M6P/IGF2R; Cation-independent mannose-6-phosphate receptor; CI Man-6-P receptor; CI-MPR; 300 kDa mannose 6-phosphate receptor; Insulin-like growth factor II receptor; IGF-II receptor; M6P/IGF2 receptor
Target 2
MET
Gene ID
UniProt ID
Alternative Names
MET; MET proto-oncogene, receptor tyrosine kinase; HGFR; AUTS9; RCCP2; c-Met; hepatocyte growth factor receptor; SF receptor; HGF receptor; HGF/SF receptor; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met; met proto-oncogene tyrosine kinase
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

See other bsAb targets related to "MET"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-IGF2R x Anti-MET Bispecific aptamer (DNA/DNA) (KN-0825-JL74). Click the button below to contact us or submit your feedback about this product.